ID

28927

Descripción

Study Evaluating PPM-204 In Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00425919

Link

https://clinicaltrials.gov/show/NCT00425919

Palabras clave

Versiones (1)
  1. 16/2/18 16/2/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

16 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus NCT00425919

Inglés

Eligibility Diabetes Mellitus NCT00425919

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women of non-childbearing potential, 18 to 70 years old
Descripción

Childbearing Potential Absent | Age

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0001779
subjects currently treated with diet and exercise alone and subjects receiving a single oral antidiabetic medication
Descripción

Diet therapy | Remedial exercise | Antidiabetic Oral Single

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0203988
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C0205171
bmi > 23 and < 43
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
for subjects currently treated with 1 antidiabetic medication: hba1c is greater than or equal to 6.8% and less than or equal to 8.5%.
Descripción

Antidiabetics Therapeutic procedure | Glucohemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0202054
for subjects not currently treated with antidiabetic medications: hba1c is greater than or equal to 7.2% and less than or equal to 9.0%
Descripción

Antidiabetics Therapeutic procedure Absent | Glucohemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0332197
UMLS CUI [2]
C0202054
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects requiring insulin therapy
Descripción

Patient need for Insulin regime

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0557978
subjects currently receiving 2 or more oral antidiabetic medications
Descripción

Antidiabetics Oral Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1265611
subjects requiring systemic corticosteroids, unless treatment was discontinued at least 4 weeks before the screening visit
Descripción

Patient need for CORTICOSTEROIDS FOR SYSTEMIC USE | Exception Procedure discontinued (treatment)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C3653708
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0520253
subjects receiving warfarin
Descripción

Warfarin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0043031
subjects currently receiving thiazolidinediones, unless treatment was discontinued 8 weeks before the screening visit
Descripción

Thiazolidinediones | Exception Procedure discontinued (treatment)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1257987
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0520253
significant diabetic complications (retinopathy, nephropathy, symptomatic neuropathy)
Descripción

Complications of Diabetes Mellitus | Retinal Diseases | Kidney Diseases | Neuropathy Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342257
UMLS CUI [2]
C0035309
UMLS CUI [3]
C0022658
UMLS CUI [4,1]
C0442874
UMLS CUI [4,2]
C0231220
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus NCT00425919

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Childbearing Potential Absent | Age
Item
men and women of non-childbearing potential, 18 to 70 years old
boolean
C3831118 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Diet therapy | Remedial exercise | Antidiabetic Oral Single
Item
subjects currently treated with diet and exercise alone and subjects receiving a single oral antidiabetic medication
boolean
C0012159 (UMLS CUI [1])
C0203988 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0205171 (UMLS CUI [3,3])
Body mass index
Item
bmi > 23 and < 43
boolean
C1305855 (UMLS CUI [1])
Antidiabetics Therapeutic procedure | Glucohemoglobin measurement
Item
for subjects currently treated with 1 antidiabetic medication: hba1c is greater than or equal to 6.8% and less than or equal to 8.5%.
boolean
C0935929 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0202054 (UMLS CUI [2])
Antidiabetics Therapeutic procedure Absent | Glucohemoglobin measurement
Item
for subjects not currently treated with antidiabetic medications: hba1c is greater than or equal to 7.2% and less than or equal to 9.0%
boolean
C0935929 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0202054 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Patient need for Insulin regime
Item
subjects requiring insulin therapy
boolean
C0686904 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
Antidiabetics Oral Quantity
Item
subjects currently receiving 2 or more oral antidiabetic medications
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Patient need for CORTICOSTEROIDS FOR SYSTEMIC USE | Exception Procedure discontinued (treatment)
Item
subjects requiring systemic corticosteroids, unless treatment was discontinued at least 4 weeks before the screening visit
boolean
C0686904 (UMLS CUI [1,1])
C3653708 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
Warfarin
Item
subjects receiving warfarin
boolean
C0043031 (UMLS CUI [1])
Thiazolidinediones | Exception Procedure discontinued (treatment)
Item
subjects currently receiving thiazolidinediones, unless treatment was discontinued 8 weeks before the screening visit
boolean
C1257987 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
Complications of Diabetes Mellitus | Retinal Diseases | Kidney Diseases | Neuropathy Symptomatic
Item
significant diabetic complications (retinopathy, nephropathy, symptomatic neuropathy)
boolean
C0342257 (UMLS CUI [1])
C0035309 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0442874 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial